Cargando…
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the app...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197778/ https://www.ncbi.nlm.nih.gov/pubmed/30364598 http://dx.doi.org/10.1016/j.omtm.2018.09.002 |